| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 63 |
| 1 | PREDNISOLONE ORAL | 63 |
| 2 | PREDNISOLONE ORAL SOLUTION | 63 |
| 3 | RITUXIMAB | 52 |
| 4 | MYCOPHENOLATE MOFETIL | 48 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 48 |
| 6 | CYCLOSPORINE | 47 |
| 7 | CYCLOPHOSPHAMIDE | 46 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 46 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 46 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CIDOFOVIR ANHYDROUS | 15 | 0.0104 |
| 1 | ALPHA1-PROTEINASE INHIBITOR (HUMAN) | 10 | 0.0052 |
| 2 | PROBENECID | 4 | 0.0034 |
| 3 | GILTERITINIB | 13 | 0.0032 |
| 4 | CARMUSTINE | 15 | 0.0032 |
| 5 | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | 10 | 0.0031 |
| 6 | CLOFARABINE | 5 | 0.0022 |
| 7 | NADOFARAGENE FIRADENOVEC-VNCG | 1 | 0.0019 |
| 8 | VALERIAN | 1 | 0.0014 |
| 9 | ALEMTUZUMAB | 25 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 111 |
| 1 | Alkylating Drug [EPC] | 68 |
| 2 | Kinase Inhibitor [EPC] | 54 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 52 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 47 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 43 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 33 |
| 7 | Janus Kinase Inhibitor [EPC] | 28 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 25 |
| 9 | Topoisomerase Inhibitor [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human alpha-1 Proteinase Inhibitor [EPC] | 10 | 0.0024 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 25 | 0.0013 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 47 | 0.0004 |
| 5 | Complement Inhibitor [EPC] | 20 | 0.0004 |
| 6 | Human Immunoglobulin G [EPC] | 7 | 0.0003 |
| 7 | Topoisomerase Inhibitor [EPC] | 25 | 0.0003 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 7 | 0.0003 |
| 9 | Alkylating Drug [EPC] | 68 | 0.0003 |